Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uveitis and blindness in a closed herd of Equidae following leptospiral infection.

Frontiers in veterinary science·2025

Same author

Prognosis and impact of equine recurrent uveitis.

Equine veterinary journal·2015

Same author

International Equine Ophthalmology Consortium (IEOC) Symposium.

Equine veterinary journal·2009

Same author

Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.

Veterinary ophthalmology·2008

Same author

Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses.

Journal of veterinary pharmacology and therapeutics·2008

Same author

Proteinases of the cornea and preocular tear film.

Veterinary ophthalmology·2007

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Equine recurrent uveitis: the viewpoint from the USA.

¹North Carolina State University, Raleigh, North Carolina, USA.

Equine Veterinary Journal. Supplement

|October 14, 2010

Summary

Equine recurrent uveitis (ERU) is a common immune-mediated eye disease in horses. Accurate diagnosis is crucial, as ERU differs from primary uveitis, and standard treatments may require advanced therapies for refractory cases.

Area of Science:

Veterinary Ophthalmology
Equine Internal Medicine
Immunology

Background:

Equine recurrent uveitis (ERU) is a prevalent condition in horses, particularly in the USA.
Misdiagnosis is common, often stemming from confusion with primary corneal or uveal diseases.
ERU is an immune-mediated condition, distinct from a single episode of primary uveitis.

Purpose of the Study:

To highlight the importance of accurate diagnosis in equine recurrent uveitis.
To differentiate ERU from primary uveitis.
To discuss treatment strategies for ERU, including standard and advanced therapies.

Main Methods:

Review of clinical presentations and diagnostic challenges in ERU.
Comparison of pathological and etiological factors between ERU and primary uveitis.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Intravitreal Injections in the Ovine Eye

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jun 8, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Intravitreal Injections in the Ovine Eye

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Evaluation of therapeutic outcomes for standard and advanced ERU treatments.

Main Results:

Frequent misdiagnosis of ERU occurs when primary corneal or uveal disease is present.
Standard anti-inflammatory therapy effectively manages most ERU cases.
Advanced therapies like drug delivery devices or vitrectomy are necessary for treatment-resistant horses.

Conclusions:

Distinguishing ERU from primary uveitis is critical for appropriate management.
While standard therapy is often sufficient, advanced interventions are vital for non-responsive ERU cases.
Continued research into ERU pathogenesis and treatment is warranted.